Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Does systemic inflammation increase frequency and severity of menopausal hot flashes and night sweats?

Systemic inflammation is associated with increased frequency and severity of menopausal vasomotor symptoms such as hot flashes and night sweats.

PlausibleJune 19, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Systemic inflammation is associated with greater frequency and severity of menopausal vasomotor symptoms such as hot flashes and night sweats.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Clinical and mechanistic evidence links higher levels of inflammatory biomarkers with more frequent and intense vasomotor symptoms. Pro-inflammatory signaling is proposed to sensitize hypothalamic thermoregulatory pathways and narrow the thermoneutral zone, amplifying neurovascular instability that triggers vasodilation and sweating.

Verified conclusion

The relationship between systemic inflammation and menopausal vasomotor symptoms (VMS), such as hot flashes and night sweats, is supported by a growing body of clinical and mechanistic research. While the directionality of this relationship continues to be studied, evidence indicates that inflammatory markers often correlate with the intensity and frequency of these symptoms.

Clinical evidence of association

Cross-sectional and longitudinal data suggest that women with more severe VMS exhibit higher profiles of systemic inflammatory markers.

  • Inflammatory Markers: Research indicates that higher levels of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), and interleukin-6 (IL-6) are positively correlated with VMS frequency and severity.
  • Symptom Intensity: In clinical cohorts, women reporting severe hot flashes have demonstrated significantly higher levels of TNF-α (approximately 51% higher) and IL-8 (37% higher) compared to those with mild symptoms.
  • Temporal Relationships: Findings from the Study of Women's Health Across the Nation (SWAN) suggest that elevations in hs-CRP and IL-6 may precede or coincide with the onset of VMS, pointing toward inflammation as a potential driver of symptom severity.

Mechanistic explanations

The link between inflammation and VMS likely involves the disruption of the brain's thermoregulatory center in the hypothalamus.

  • Hypothalamic Sensitivity: Estrogen withdrawal triggers the KNDy (kisspeptin/neurokinin B/dynorphin) neuron complex, which projects to the preoptic area (POA) of the hypothalamus. This shifts the internal thermoregulatory set point.
  • Cytokine Interference: Pro-inflammatory cytokines are hypothesized to sensitize these hypothalamic pathways. This sensitization narrows the "thermoneutral zone," making the body more reactive to minor temperature changes and triggering heat-dissipation responses like vasodilation and sweating.
  • Neurovascular Dysfunction: Inflammation may further exacerbate the neurovascular instability characteristic of the menopausal transition, contributing to the physiological experience of a "flash."

Bottom line

Systemic inflammation is strongly associated with increased frequency and severity of hot flashes and night sweats, likely by amplifying hypothalamic instability and narrowing the body's thermoneutral zone during the menopausal transition.

References

  1. The relationship between hot flashes and fatty acid binding protein 2 in postmenopausal women — dx.plos.org ↗
  2. TRAJECTORIES OF C-REACTIVE PROTEIN OVER THE MENOPAUSE TRANSITION: THE STUDY OF WOMEN’S HEALTH ACROSS THE NATION — pmc.ncbi.nlm.nih.gov ↗
  3. The effect of menopausal hormone therapy on biomarkers of systemic inflammation — ujhw.med-expert.com.ua ↗
  4. Effects of menopause on temperature regulation — pmc.ncbi.nlm.nih.gov ↗
  5. Glutamatergic and GABAergic neurons in the preoptic area of the hypothalamus play key roles in menopausal hot flashes — pmc.ncbi.nlm.nih.gov ↗
  6. Menopausal Hot Flashes: A Concise Review — pmc.ncbi.nlm.nih.gov ↗
  7. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: A novel hypothesis on the mechanism of hot flushes — pmc.ncbi.nlm.nih.gov ↗
  8. Cutaneous and hemodynamic responses during hot flashes in symptomatic postmenopausal women — pmc.ncbi.nlm.nih.gov ↗
  9. Circulating interleukin-8 and tumor necrosis factor-α are associated with hot flashes in healthy postmenopausal women — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→